Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ChemTrak in OEM (original equipment manufacturer) drug monitoring call from Pfizer:

This article was originally published in Clinica

Executive Summary

Pfizer and ChemTrak have signed an agreement for ChemTrak to develop a fingerstick, whole blood test for one of Pfizer's drugs in development. ChemTrak will be paid $400,000 in quarterly instalments and will become the sole manufacturer. This is ChemTrak's first OEM venture based around the AccuMeter technology. The Sunnyvale, California-based company has three products under its own name: A home cholesterol test, an H pylori test and a recently FDA-approved theophylline test, to measure the level of the asthma drug in the blood.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT081703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel